Scientific Opinion on the substantiation of a health claim related to a Uroval® and urinary tract infection pursuant to Article 14 of Regulation (EC) No 1924/2006

Documenti analoghi

• Scientific Opinion on the substantiation of a health claim related to proanthocyanidins in Urell® and reduction of bacterial colonisation of the urinary tract by inhibition of the adhesion of P-fimbriated <em>E. coli</em> to uroepithelial cells pursuant to Article 13(5) of Regulation (EC) No 1924/2006
  di: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Pubblicazione: (2013-07-01)
• Scientific Opinion on the substantiation of a health claim related to CranMax® and reduction of the risk of urinary tract infection by inhibiting the adhesion of certain bacteria in the urinary tract pursuant to Article 14 of Regulation (EC) No 1924/2006
  di: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Pubblicazione: (2014-05-01)
• Scientific Opinion on the substantiation of a health claim related to a Uroval® and urinary tract infection pursuant to Article 14 of Regulation (EC) No 1924/2006
  di: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Pubblicazione: (2009-12-01)
• Pacran®, a powder obtained from cranberries, and defence against bacterial pathogens in the lower urinary tract: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
  di: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
  Pubblicazione: (2025-04-01)
• Scientific Opinion on the substantiation of a health claim related to choline and "development of brain" pursuant to Article 14 of Regulation (EC) No 1924/2006
  di: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Pubblicazione: (2014-05-01)